“…79 Virosome adjuvant system consists of an influenza virus envelope devoid of inner core and genetic information, with the influenza virus surface antigens neuraminidase and hemagglutinin integrated into phosphatidylcholine bilayer liposomes. 80 Virosomal influenza vaccines demonstrated to induce antibody titers comparable to the not-adjuvanted, IM, split/subunit vaccines, against vaccine homologous strains. Only one study evaluated the performances of virosomal influenza vaccine against circulating viruses that did not have a good match with vaccine strains, due to antigenic drift.…”